Press Releases

BASi (Bioanalytical Systems, Inc.) today announced the launch of Culex® NxT, the latest generation of the Company’s proprietary in vivo automated sampling system. The Company is now taking orders for Culex NxT and expects to begin shipping in...

Celator Pharmaceuticals today announced that the first patient has been treated in its Phase 3, multicenter, randomized, open-label clinical trial of CPX-351 (cytarabine:daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy (“7+3”) as first-line therapy in patients 60-75...

A wireless physiological monitoring system designed by the Department of Biomedical Engineering (BME) of National Cheng Kung University (NCKU), southern Taiwan, has proved to increase medical efficiency and safety for dialysis patients. BME was...

Oncodesign, a drug discovery company and oncology pharmacology service provider and the Laboratory for Neurobiology and Gene Therapy (LNGT) at the department of neurosciences at the KU Leuven, an expert academic group exploring the roles of LRRK2 and...

Adaptimmune today announces the release of preliminary results from an early phase clinical study using patients’ own T cells that have been genetically altered to attack multiple myeloma (MM) cells.  Lead investigators for the study presented today in...

Quintiles today announced that its flagship central laboratory in the U.S. received accreditation from the College of American Pathologists (CAP) Biorepository Accreditation Program. The first of its kind, this accreditation was developed to ensure biorepositories are following best...

According to Dr. Samuel Dyer, Chairman of the Board of the MSL Society, “As the MSL role continues to rapidly grow and play an ever increasingly important role in the success of pharmaceutical and biotech companies, there has...